CONTinuous Infusion Versus Intermittent Dosing of ceftaZidime/AVIbactam in Critically Ill Patients
CONTinuous Infusion Versus Intermittent Dosing of ceftaZidime/AVIbactam in Critically Ill Patients
Not yet recruiting · NCT06811727 · Registry updated 2025-04-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CONTinuous Infusion Versus Intermittent Dosing of ceftaZidime/AVIbactam in Critically Ill Patients | Bacterial Infections and Mycoses, Critical Illness, Disease Attributes, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pseudomonas infection, bacterial infectious disease, gram-negative bacterial infections | Not yet recruiting | Phase 4 | 2025-04-22 | NCT06811727 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Daniel Lovrić | 1 |
| Ivan Šitum, MD | 1 |
| Mirna Momčilović | 1 |
| UHC Zagreb, Zagreb, Croatia | 1 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||